Goldenwell Biotech Stock Technical Analysis
| GWLL Stock | USD 1.05 0.00 0.00% |
As of the 10th of February, Goldenwell Biotech retains the Standard Deviation of 11.22, market risk adjusted performance of (4.55), and Risk Adjusted Performance of (0.11). Goldenwell Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Goldenwell Biotech standard deviation and value at risk to decide if Goldenwell Biotech is priced fairly, providing market reflects its last-minute price of 1.05 per share. Given that Goldenwell Biotech is a hitting penny stock territory we urge to closely look at its jensen alpha.
Goldenwell Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Goldenwell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GoldenwellGoldenwell |
Goldenwell Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Goldenwell Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Goldenwell Biotech.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Goldenwell Biotech on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Goldenwell Biotech or generate 0.0% return on investment in Goldenwell Biotech over 90 days. Goldenwell Biotech is related to or competes with Grupo KUO, RCL Foods, Zinzino AB, Ausnutria Dairy, Select Harvests, Perusahaan Perkebunan, and Origin Enterprises. Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States More
Goldenwell Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Goldenwell Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Goldenwell Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (13.79) |
Goldenwell Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Goldenwell Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Goldenwell Biotech's standard deviation. In reality, there are many statistical measures that can use Goldenwell Biotech historical prices to predict the future Goldenwell Biotech's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.76) | |||
| Total Risk Alpha | (2.96) | |||
| Treynor Ratio | (4.56) |
Goldenwell Biotech February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (4.55) | |||
| Mean Deviation | 4.37 | |||
| Coefficient Of Variation | (654.39) | |||
| Standard Deviation | 11.22 | |||
| Variance | 125.95 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.76) | |||
| Total Risk Alpha | (2.96) | |||
| Treynor Ratio | (4.56) | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (13.79) | |||
| Skewness | (1.83) | |||
| Kurtosis | 23.44 |
Goldenwell Biotech Backtested Returns
Goldenwell Biotech holds Efficiency (Sharpe) Ratio of -0.0956, which attests that the entity had a -0.0956 % return per unit of risk over the last 3 months. Goldenwell Biotech exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Goldenwell Biotech's Risk Adjusted Performance of (0.11), standard deviation of 11.22, and Market Risk Adjusted Performance of (4.55) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Goldenwell Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Goldenwell Biotech is expected to be smaller as well. At this point, Goldenwell Biotech has a negative expected return of -0.77%. Please make sure to check out Goldenwell Biotech's standard deviation, value at risk, as well as the relationship between the Value At Risk and day typical price , to decide if Goldenwell Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.38 |
Poor reverse predictability
Goldenwell Biotech has poor reverse predictability. Overlapping area represents the amount of predictability between Goldenwell Biotech time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Goldenwell Biotech price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Goldenwell Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Goldenwell Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Goldenwell Biotech Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Goldenwell Biotech across different markets.
About Goldenwell Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Goldenwell Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Goldenwell Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Goldenwell Biotech price pattern first instead of the macroeconomic environment surrounding Goldenwell Biotech. By analyzing Goldenwell Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Goldenwell Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Goldenwell Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Goldenwell Biotech February 10, 2026 Technical Indicators
Most technical analysis of Goldenwell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Goldenwell from various momentum indicators to cycle indicators. When you analyze Goldenwell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (4.55) | |||
| Mean Deviation | 4.37 | |||
| Coefficient Of Variation | (654.39) | |||
| Standard Deviation | 11.22 | |||
| Variance | 125.95 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.76) | |||
| Total Risk Alpha | (2.96) | |||
| Treynor Ratio | (4.56) | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (13.79) | |||
| Skewness | (1.83) | |||
| Kurtosis | 23.44 |
Goldenwell Biotech February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Goldenwell stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 1.05 | ||
| Day Typical Price | 1.05 | ||
| Price Action Indicator | 0.00 |
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.